Twelve-Month Follow-Up of Dexamethasone Implants for Macular Edema from Various Diseases in Vitrectomized and Nonvitrectomized Eyes

Twelve-Month Follow-Up of Dexamethasone Implants for Macular Edema from Various Diseases in Vitrectomized and Nonvitrectomized Eyes

Purpose. To evaluate the best-corrected visual acuity (BCVA), central retinal thickness (CRT), and the number of dexamethasone implants needed to treat cystoid macular edema (CME) from various etiologies over 12 months in vitrectomized and nonvitrectomized eyes. Methods. This multicenter retrospecti...

Full description

Saved in:

Bibliographic Details
Main Authors:	Eduardo A. Novais, Mauricio Maia, Paulo Augusto de Arruda Mello Filho, João Rafael de Oliveira Dias, José Maurício B. B. Garcia, Gabriel C. de Andrade, Ricardo N. Louzada, Marcos Ávila, André Maia, J. Fernando Arevalo, Lihteh Wu, Maria Berrocal, Emmerson Badaró, Michel Farah
Format:	Article
Language:	English
Published:	Wiley 2016-01-01
Series:	Journal of Ophthalmology
Online Access:	http://dx.doi.org/10.1155/2016/7984576
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparison of the Effect of Intravitreal Dexamethasone Implant in Vitrectomized and Nonvitrectomized Eyes for the Treatment of Diabetic Macular Edema
by: Sadık Görkem Çevik, et al.
Published: (2018-01-01)

Effectiveness of Intravitreal Dexamethasone Implant Treatment for Diabetic Macular Edema in Vitrectomized Eyes
by: Hüseyin Baran Özdemir, et al.
Published: (2019-12-01)

Comparison of Intravitreal Dexamethasone Implant and Ranibizumab in Vitrectomized Eyes with Diabetic Macular Edema
by: Jia-Kang Wang, et al.
Published: (2021-01-01)

Anti-VEGF for the Management of Diabetic Macular Edema
by: Francisco Rosa Stefanini, et al.
Published: (2014-01-01)

Effect of Dexamethasone Implant on Subfoveal Choroidal Thickness in Early Period in Vitrectomized Eyes with Diabetic Macular Edema
by: A. Altun, et al.
Published: (2021-01-01)

Spectral-Domain Optical Coherence Tomography for Macular Edema
by: Emmerson Badaró, et al.
Published: (2014-01-01)

Evaluation of the Quality of Visual Function and Life of Patients with Diabetic Macular Edema with Vitrectomized and Non-Vitrectomized Eyes on Steroid Therapy
by: D. D. Arzhukhanov, et al.
Published: (2023-12-01)

The Effects of Slow-Release Dexamethasone in the Treatment of Diabetic Macular Edema
by: Enzo Maria Vingolo, et al.
Published: (2025-01-01)

Repeat Intravitreal Dexamethasone Implant for Refractory Cystoid Macular Edema in Syphilitic Uveitis
by: Cassandra C. Lautredou, et al.
Published: (2018-01-01)

Nonvitrectomizing vitreous surgery for idiopathic epiretinal membrane
by: Shuyue Xue, et al.
Published: (2025-07-01)

Efficacy of Aflibercept (8 mg) for Diabetic Macular Edema in Vitrectomized Eyes Refractory to the Other Anti-VEGF Drug Therapies: A Report of Three Cases
by: Kashiwagi I, et al.
Published: (2025-04-01)

Evaluation of Predictive Factors for Successful Intravitreal Dexamethasone in Pseudophakic Cystoid Macular Edema
by: Vinodh Kakkassery, et al.
Published: (2017-01-01)

Twelve-Month Outcomes and Optical Coherence Tomography (OCT) Biomarkers After Intravitreal Dexamethasone Implantation in Pseudophakic Eyes with Post-Vitrectomy Cystoid Macular Edema (CME)—Refractory to Medical Therapy
by: Francesco Pignatelli, et al.
Published: (2025-01-01)

Intravitreal Dexamethasone Implant in the Treatment of Refractory Uveitic Macular Edema: A Case Report
by: Anisha Seth, et al.
Published: (2016-04-01)

Outcomes of intravitreal dexamethasone implant (Ozurdex®) in patients with post-surgical macular edema – a real-world scenario
by: Elder Ohara de Oliveira Júnior, et al.
Published: (2025-01-01)

Efficacy and Safety of a Dexamethasone Implant in Patients with Diabetic Macular Edema at Tertiary Centers in Korea
by: Byung Gil Moon, et al.
Published: (2016-01-01)

OCT biomarkers as predictors of visual improvement in diabetic macular edema eyes receiving dexamethasone implants
by: Giacomo Visioli, et al.
Published: (2023-06-01)

Time-in-Range Analysis of Responses after Intravitreal Dexamethasone Therapy in Eyes with Diabetic Macular Edema
by: Igor Kozak, MD, PhD, et al.
Published: (2025-09-01)

Comparison of Aqueous Depth Changes Following Cataract Surgery in Vitrectomized and Non-Vitrectomized Fellow Eyes
by: Mercè Guarro, et al.
Published: (2025-06-01)

Dexamethasone Intravitreal Implant (Ozurdex) for Long-Term Macular Edema after Epiretinal Membrane Peeling Surgery
by: Yo-Chen Chang, et al.
Published: (2018-01-01)

Combined Phacoemulsification and Intravitreal Dexamethasone Implant (Ozurdex®) in Diabetic Patients with Coexisting Cataract and Diabetic Macular Edema
by: Claudio Furino, et al.
Published: (2017-01-01)

Correction: OCT biomarkers as predictors of visual improvement in diabetic macular edema eyes receiving dexamethasone implants
by: Giacomo Visioli, et al.
Published: (2025-03-01)

Efficacy and safety of dexamethasone versus intravitreal aflibercept implants for macular edema: a systematic review and meta-analysis
by: Khaled Moghib, et al.
Published: (2025-04-01)

Small-Gauge Pars Plana Vitrectomy for the Management of Symptomatic Posterior Vitreous Detachment after Phacoemulsification and Multifocal Intraocular Lens Implantation: A Pilot Study from the Pan-American Collaborative Retina Study Group
by: Rodrigo M. Navarro, et al.
Published: (2015-01-01)

Intravitreal Dexamethasone Implant in Anti-Vascular Endothelial Growth Factor Pretreated Diabetic Macular Edema—A Swiss Cohort Study
by: Ferhat Turgut, et al.
Published: (2024-09-01)

Analysis of Morphologic and Functional Outcomes in Macular Edema due to Central Retinal Vein Occlusion Treated with Intravitreal Dexamethasone Implant
by: Alfredo Niro, et al.
Published: (2018-01-01)

Efficacy of Intravitreal Dexamethasone Implant (Ozurdex<sup>®</sup>) in Naïve and Refractory Patients with Different Morphological Subtypes of Diabetic Macular Edema
by: Panagiotis Stavrakas, et al.
Published: (2025-03-01)

Real-Life Management of Diabetic Macular Edema with Dexamethasone Intravitreal Implant: A Retrospective Analysis of Long-Term Clinical Outcomes
by: Massimo Nicolò, et al.
Published: (2020-01-01)

Postoperative, or pseudophakic, macular edema
by: I. E. Ioshin
Published: (2020-12-01)

Updates in the Management of Diabetic Macular Edema
by: Christopher Mathew, et al.
Published: (2015-01-01)

Surgical treatment of diabetic macular edema
by: R. R. Fayzrakhmanov, et al.
Published: (2024-10-01)

Corticosteroid Treatment in Diabetic Macular Edema
by: Burcu Nurözler Tabakcı, et al.
Published: (2017-06-01)

Combination Therapy for Diabetic Macular Edema
by: Dinah Zur, et al.
Published: (2012-01-01)

Three-year outcomes of cystotomy and fibrinogen clot removal for diabetic macular edema with subfoveal cystoid macular edema
by: Hiroko Yamada, et al.
Published: (2025-05-01)

Preretinal drug deposits mimicking exudates in a vitrectomized eye!
by: Yamini Sahu, et al.
Published: (2025-05-01)

Costs and Quality of Life in Diabetic Macular Edema: Canadian Burden of Diabetic Macular Edema Observational Study (C-REALITY)
by: John R. Gonder, et al.
Published: (2014-01-01)

When less is more: the role of non-vitrectomized vitreous surgery in retinal diseases
by: Andrew D. Brown, et al.
Published: (2025-08-01)

Effects of Dexamethasone Intravitreal Implant on Multifocal Electroretinography in Diabetic Macular Oedema
by: Tranos P, et al.
Published: (2024-11-01)

Optical Coherence Tomography Predictors of Favorable Functional Response in Naïve Diabetic Macular Edema Eyes Treated with Dexamethasone Implants as a First-Line Agent
by: Alessandro Meduri, et al.
Published: (2021-01-01)

Predictive Value of Optical Coherence Tomography Biomarkers in Patients with Persistent Diabetic Macular Edema Undergoing Cataract Surgery Combined with a Dexamethasone Intravitreal Implant
by: Giuseppe Fasolino, et al.
Published: (2025-05-01)